Taisho Pharmaceutical Co. and Tanabe Seiyaku Co. have given up their plan to integrate under a single holding company due to differences in corporate culture, the two companies said Monday.

During negotiations toward finalizing the integration, the two firms found they had wide gaps of opinion on the purpose of the holding company and plans for the subsidiaries’ operations, executives of the two companies said.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.